Regular biography
Prof. Roger Schibli is a Professor in the Department of Chemistry at ETH Zurich. His research focuses on IPW and Radiopharmaceutical Science. Prof. Schibli's work is detailed on his profile page, which provides information about his research interests and academic contributions. His professional activities are supported by the university's resources and infrastructure.
Scholar-generated biography
Roger Schibli is a researcher in Radiopharmaceutical Sciences, focusing on the development of radiolabeled compounds for biomedical applications. His work involves the synthesis and characterization of organometallic complexes, particularly those involving technetium-99m (99mTc) and rhenium-188 (188Re), for use in imaging and therapy. Schibli's research explores the chemical behavior of metal carbonyl and aqua complexes in aqueous environments, aiming to improve the stability and functionality of radiopharmaceuticals. He has contributed to the design of ligands for targeted radionuclide therapy and the development of chelating systems for biomolecule labeling. His studies also include the application of radiopharmaceuticals in cancer targeting and imaging, with an emphasis on improving specificity and therapeutic efficacy.